AKT1 and breast carcinoma: Thus some types of cancer therapy may target intracellular pathways that drive uncontrolled cell growth: examples include inhibitors of the MAPK or P13/AKT/mTOR pathways, such as trametinib for melanoma and everolimus for breast cancer [93,109].